Gujarat Themis Biosyn Limited (GUJTHEM.BO)
INR 307.0
(-0.98%)
INR 307.0
(-0.98%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.69 Billion INR | 14.0% |
| 2022 | 1.48 Billion INR | 30.46% |
| 2021 | 1.14 Billion INR | 26.28% |
| 2020 | 904.25 Million INR | 6.41% |
| 2019 | 849.76 Million INR | 107.01% |
| 2018 | 410.49 Million INR | 5.8% |
| 2017 | 387.99 Million INR | 9.03% |
| 2016 | 355.87 Million INR | 9.08% |
| 2015 | 326.24 Million INR | 3.77% |
| 2014 | 314.4 Million INR | 4.0% |
| 2013 | 302.3 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 388.27 Million INR | -7.58% |
| 2024 Q2 | 347.16 Million INR | -10.59% |
| 2023 Q3 | 388.58 Million INR | -2.0% |
| 2023 Q4 | 420.11 Million INR | 8.11% |
| 2023 FY | 1.69 Billion INR | 14.0% |
| 2023 Q1 | 495.88 Million INR | 76.01% |
| 2023 Q2 | 396.53 Million INR | -20.03% |
| 2022 Q3 | 281.65 Million INR | -40.94% |
| 2022 Q2 | 476.9 Million INR | 6.11% |
| 2022 Q1 | 449.44 Million INR | 59.94% |
| 2022 FY | 1.48 Billion INR | 30.46% |
| 2022 Q4 | 281.72 Million INR | 0.03% |
| 2021 Q2 | 350.46 Million INR | 8.03% |
| 2021 Q4 | 281.01 Million INR | 51.05% |
| 2021 Q1 | 324.4 Million INR | 39.24% |
| 2021 FY | 1.14 Billion INR | 26.28% |
| 2021 Q3 | 186.03 Million INR | -46.92% |
| 2020 Q2 | 271.97 Million INR | 73.64% |
| 2020 Q1 | 156.63 Million INR | -40.23% |
| 2020 FY | 904.25 Million INR | 6.41% |
| 2020 Q4 | 232.98 Million INR | -4.53% |
| 2020 Q3 | 244.03 Million INR | -10.27% |
| 2019 Q2 | 164.65 Million INR | 40.64% |
| 2019 FY | 849.76 Million INR | 107.01% |
| 2019 Q4 | 262.04 Million INR | -14.36% |
| 2019 Q3 | 305.99 Million INR | 85.85% |
| 2019 Q1 | 117.07 Million INR | 14.66% |
| 2018 Q2 | 105.05 Million INR | 1.21% |
| 2018 Q1 | 103.79 Million INR | 4.28% |
| 2018 Q4 | 102.1 Million INR | 4.1% |
| 2018 FY | 410.49 Million INR | 5.8% |
| 2018 Q3 | 98.07 Million INR | -6.64% |
| 2017 FY | 387.99 Million INR | 9.03% |
| 2017 Q4 | 99.53 Million INR | 1.24% |
| 2017 Q1 | 94.8 Million INR | -9.1% |
| 2017 Q2 | 95.33 Million INR | 0.56% |
| 2017 Q3 | 98.32 Million INR | 3.14% |
| 2016 Q3 | 85.03 Million INR | 1.29% |
| 2016 Q4 | 104.29 Million INR | 22.64% |
| 2016 Q2 | 83.95 Million INR | 0.38% |
| 2016 Q1 | 83.63 Million INR | 1.27% |
| 2016 FY | 355.87 Million INR | 9.08% |
| 2015 Q1 | 82.66 Million INR | 2.7% |
| 2015 Q4 | 82.58 Million INR | 5.15% |
| 2015 Q3 | 78.53 Million INR | -4.77% |
| 2015 Q2 | 82.46 Million INR | -0.23% |
| 2015 FY | 326.24 Million INR | 3.77% |
| 2014 Q2 | 78.61 Million INR | 2.96% |
| 2014 Q1 | 76.35 Million INR | 4.75% |
| 2014 FY | 314.4 Million INR | 4.0% |
| 2014 Q4 | 80.48 Million INR | 1.96% |
| 2014 Q3 | 78.94 Million INR | 0.42% |
| 2013 Q1 | 77.03 Million INR | 5.16% |
| 2013 Q2 | 79.39 Million INR | 3.05% |
| 2013 FY | 302.3 Million INR | 0.0% |
| 2013 Q3 | 73.06 Million INR | -7.97% |
| 2013 Q4 | 72.89 Million INR | -0.23% |
| 2012 Q4 | 73.25 Million INR | 7.05% |
| 2012 Q1 | 63.64 Million INR | 17.46% |
| 2012 Q3 | 68.43 Million INR | -12.63% |
| 2012 Q2 | 78.32 Million INR | 23.06% |
| 2011 Q3 | 14.21 Million INR | 0.0% |
| 2011 Q4 | 54.18 Million INR | 281.3% |
| 2008 Q4 | 35.41 Million INR | 0.0% |
| 2007 Q4 | 45.09 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 10.48 Million INR | -16089.65% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | -61.926% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -324.312% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -358.75% |
| Sunil Healthcare Limited | 901.91 Million INR | -88.29% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -9138.489% |
| MedPlus Health Services Limited | 56.24 Billion INR | 96.981% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -280.689% |
| Patidar Buildcon Limited | 2.3 Million INR | -73479.679% |
| Roopa Industries Limited | 715.53 Million INR | -137.335% |
| Smruthi Organics Limited | 1.27 Billion INR | -33.044% |
| Trident Lifeline Limited | 446.28 Million INR | -280.523% |
| PANJON LTD. | 125.52 Million INR | -1252.936% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -1023.748% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -253.982% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 73.753% |
| Crestchem Limited | 212.56 Million INR | -698.929% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -30487.518% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | -152.408% |
| Tyche Industries Limited | 696.83 Million INR | -143.704% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 51.222% |
| Trimurthi Limited | 42.23 Million INR | -3920.595% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | -127.726% |
| Norris Medicines Limited | 56.35 Million INR | -2913.37% |
| Zenlabs Ethica Limited | 585.63 Million INR | -189.981% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | -35.412% |
| ANG Lifesciences India Limited | 1.46 Billion INR | -16.229% |
| Parmax Pharma Limited | 154.24 Million INR | -1000.999% |
| Veerhealth Care Limited | 142.13 Million INR | -1094.801% |
| Deccan Health Care Limited | 597.28 Million INR | -184.321% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 63.364% |
| Makers Laboratories Limited | 1.03 Billion INR | -63.663% |
| Lactose (India) Limited | 1.13 Billion INR | -49.111% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -328.388% |
| Zenith Healthcare Limited | 144.71 Million INR | -1073.476% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -216.318% |
| Bacil Pharma Limited | - INR | -Infinity% |
| PRAVEG LIMITED | 915.96 Million INR | -85.402% |
| Denis Chem Lab Limited | 1.67 Billion INR | -1.192% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 44.714% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | -19.621% |
| Colinz Laboratories Limited | 70.29 Million INR | -2315.812% |
| Godavari Drugs Limited | 1.56 Billion INR | -8.366% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -151797.943% |
| Zenotech Laboratories Limited | 368.08 Million INR | -361.361% |
| Panchsheel Organics Limited | 1.05 Billion INR | -61.399% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | -34.891% |
| Vivanza Biosciences Limited | 278.89 Million INR | -508.916% |
| Phaarmasia Limited | 305.93 Million INR | -455.095% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 87.477% |
| Medi-Caps Limited | 265.63 Million INR | -539.305% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -368.147% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 2.586% |
| Mercury Laboratories Limited | 755.59 Million INR | -124.754% |
| Gennex Laboratories Limited | 867.14 Million INR | -95.84% |
| BDH Industries Limited | 858.31 Million INR | -97.856% |
| Coral Laboratories Limited | 836.6 Million INR | -102.99% |
| Concord Drugs Limited | 449.24 Million INR | -278.016% |
| Bharat Parenterals Limited | 2.59 Billion INR | 34.535% |
| Beryl Drugs Limited | 271.24 Million INR | -526.078% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -1550.712% |
| Evoq Remedies Limited | 63.09 Million INR | -2591.74% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 15.965% |
| Transchem Limited | 4.09 Million INR | -41319.986% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -1018.162% |
| Parnax Lab Limited | 1.88 Billion INR | 10.01% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -522.131% |
| Kerala Ayurveda Limited | 1.02 Billion INR | -65.945% |
| Cian Healthcare Limited | 616.95 Million INR | -175.258% |
| Trinity League India Limited | 2.95 Million INR | -57466.746% |
| Syschem (India) Limited | 2.33 Billion INR | 27.281% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | -9.266% |
| Auro Laboratories Limited | 526.99 Million INR | -222.245% |